<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Use of trade-mark by related companies</p><ul class="Section ProvisionList" id="451026"><li><p class="Subsection" id="451028"><strong><a class="sectionLabel" id="s-51"><span class="sectionLabel">51</span></a></strong> <span class="lawlabel">(1)</span> Where a company and the owner of a trade-mark that is used in Canada by that owner in association with a pharmaceutical preparation are related companies, the use by the company of the trade-mark, or a trade-mark confusing therewith, in association with a pharmaceutical preparation that at the time of that use or at any time thereafter,</p><ul class="ProvisionList"><li><p class="Paragraph" id="451029"><span class="lawlabel">(a)</span> is acquired by a person directly or indirectly from the company, and</p></li><li><p class="Paragraph" id="451030"><span class="lawlabel">(b)</span> is sold, distributed or advertised for sale in Canada in a package bearing the name of the company and the name of that person as the distributor thereof,</p></li></ul><p class="ContinuedSectionSubsection" id="451031">has the same effect, for all purposes of this Act, as a use of the trade-mark or the confusing trade-mark, as the case may be, by that owner.</p></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Where difference in composition</p><p class="Subsection" id="451032"><span class="lawlabel">(2)</span> Subsection (1) does not apply to any use of a trade-mark or a confusing trade-mark by a company referred to in that subsection in association with a pharmaceutical preparation after such time, if any, as that pharmaceutical preparation is declared by the Minister of Health, by notice published in the <cite class="XRefExternal"><a href="http://www.gazette.gc.ca/">Canada Gazette</a></cite>, to be sufficiently different in its composition from the pharmaceutical preparation in association with which the trade-mark is used in Canada by the owner referred to in subsection (1) as to be likely to result in a hazard to health.</p></li><li><p class="MarginalNoteDefinedTerm">Definition of <span class="DefinedTerm"><dfn>pharmaceutical preparation</dfn></span></p><p class="Subsection" id="451034"><span class="lawlabel">(3)</span> In this section, <span class="DefinedTerm"><dfn>pharmaceutical preparation</dfn></span> includes</p><ul class="ProvisionList"><li><p class="Paragraph" id="451036"><span class="lawlabel">(a)</span> any substance or mixture of substances manufactured, sold or represented for use in</p><ul class="ProvisionList"><li><p class="Subparagraph" id="451037"><span class="lawlabel">(i)</span> the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or the symptoms thereof, in humans or animals, or</p></li><li><p class="Subparagraph" id="451038"><span class="lawlabel">(ii)</span> restoring, correcting or modifying organic functions in humans or animals, and</p></li></ul></li><li><p class="Paragraph" id="451039"><span class="lawlabel">(b)</span> any substance to be used in the preparation or production of any substance or mixture of substances described in paragraph (a),</p></li></ul><p class="ContinuedSectionSubsection" id="451040">but does not include any such substance or mixture of substances that is the same or substantially the same as a substance or mixture of substances that is a proprietary medicine within the meaning from time to time assigned to that expression by regulations made pursuant to the <cite class="XRefExternalAct"><a href="/eng/acts/F-27">Food and Drugs Act</a></cite>.</p></li></ul><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">R.S., 1985, c. T-13, s. 51</li><li class="HistoricalNoteSubItem"> 1996, c. 8, s. 32</li></ul></div>